The Protective Effects of Melatonin Against LPS-Induced Septic Myocardial Injury: A Potential Role of AMPK-Mediated Autophagy
Open Access
- 16 April 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 11, 162
Abstract
Aim: Melatonin is an indolamine secreted by the pineal gland, as well as most of the organs and tissues. In addition to regulating circadian biology, studies have confirmed the multiple pharmacological effects of melatonin. Melatonin provides a strong defense against septic myocardial injury. However, the underlying mechanism has not been fully described. In this study, we investigated the protective effects of melatonin against lipopolysaccharide (LPS)-induced myocardial injury as well as the mechanisms involved. Methods: Mice were intraperitoneally injected with LPS to induce a septic myocardial injury model or an LPS shock model, depending on the dose of LPS. Melatonin was given (20 mg/kg/day, via intraperitoneal injection) for a week prior to LPS insult. 6 h after LPS injection, echocardiographic analysis, TUNEL staining, transmission electron microscopy (TEM), western blot, quantitative real-time PCR and ELISA were used to investigate the protective effects of melatonin against LPS induced myocardial injury. AMPK inhibitor, autophagy activator and inhibitor, siRNAs were used for further validation. Results: Survival test showed that melatonin significantly increased the survival rate after LPS-induced shock. In the sepsis model, melatonin markedly ameliorated myocardial dysfunction, decreased the release of inflammatory cytokines, activated AMP-activated protein kinase (AMPK), improved mitochondrial function, and activated autophagy. To confirm whether the protection of melatonin was mediated by AMPK and autophagy, Compound C, an AMPK inhibitor; 3-MA, an autophagy inhibitor; and Rapamycin (Rapa), an autophagy activator, were used in this study. AMPK inhibition down-regulated autophagy, abolished protection of melatonin, as indicated by significantly decreased cardiac function, increased inflammation and damaged mitochondrial function. Furthermore, autophagy inhibition by 3-MA significantly impaired the protective effects of melatonin, whereas autophagy activation by Rapa reversed LPS + Compound C induced myocardial injury. In addition, in vitro studies further confirmed the protection of melatonin against LPS-induced myocardial injury and the mechanisms involving AMPK-mediated autophagy signaling. Conclusions: In summary, our results demonstrated that melatonin protects against LPS-induced septic myocardial injury by activating AMPK mediated autophagy pathway.Keywords
This publication has 74 references indexed in Scilit:
- Myocardial Redox Hormesis Protects the Heart of Female Mice in SepsisShock, 2019
- Sepsis-induced myocardial dysfunctionCurrent Opinion in Critical Care, 2018
- Utilizing melatonin to combat bacterial infections and septic injuryBritish Journal of Pharmacology, 2017
- Melatonin reverses flow shear stress‐induced injury in bone marrow mesenchymal stem cells via activation of AMP‐activated protein kinase signalingJournal of Pineal Research, 2015
- Cardiac and hepatic role of r‐AtHSP70: basal effects and protection against ischemic and sepsis conditionsJournal of Cellular and Molecular Medicine, 2015
- Lipopolysaccharide-induced sepsis induces long-lasting affective changes in the mouseBrain, Behavior, and Immunity, 2015
- Adiponectin Ameliorates Endotoxin-Induced Acute Cardiac InjuryBioMed Research International, 2014
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003
- Epidemiology of sepsis: An updateCritical Care Medicine, 2001
- Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortalityJournal of Global Health